Warning: session_start(): open(/opt/alt/php74/var/lib/php/session/sess_8c6798c8ebd2bff3846b687275b123f6, O_RDWR) failed: Disk quota exceeded (122) in /home/useaicwl/public_html/wp-content/themes/mushroomstocks/functions.php on line 278

Warning: session_start(): Failed to read session data: files (path: /opt/alt/php74/var/lib/php/session) in /home/useaicwl/public_html/wp-content/themes/mushroomstocks/functions.php on line 278
Can CBD Oil Help Fix Healthcare? - Mushroomstocks | Mushroomstocks
Albert Labs announces Strategic Investment from Cantheon Capital LLC for First In-Human TrialsMindMed Reports Full Year 2022 Financial Results and Business HighlightsCybin to Participate in the Oppenheimer 33rd Annual Healthcare ConferenceNuminus to Participate in the Sequire Cannabis & Psychedelics Conference on Wednesday, April 5, 2023Braxia Scientific Provides Update on Proposed Irwin Transaction; Company Retains Strategic Clinical Assets and Ketamine Numinus Announces Four Peer-Reviewed Publications from its Chief Clinical Officer in 2023Irwin Naturals Signs Letter of Intent to Acquire Braxia ScientificNuminus Wellness Inc. Reports Q1 2023 ResultsIrwin Naturals and Braxia Scientific Announce Partnership for In-Human Clinical Studies Supporting Pharmaceutical CompanNuminus Develops Mushroom Tea for Use in Psychedelic ResearchIs the Psychedelic Sector Poised for a Comeback?!?PSYC + Nucleus Form New Partnership to Develop and Launch Psychedelic FinderWhat You Need to Know About Numinus Wellness…Numinus provides update on acquisition integration and announces new client financing optionsPSYC Corp’s Psychedelic Spotlight Surpasses One Million Page Views for Fourth Consecutive MonthNuminus to Participate in the H.C. Wainwright 24th Annual Global Investment Conference on September 12-14, 2022The Psychedelic Sector is Quietly Outperforming the S&P 500PSYC Completes and Publishes 2021 Audited Financials; Will Begin Audit of Q1 & Q2 2022Numinus to Participate in the H.C. Wainwright 24th Annual Global Investment Conference on September 12-14, 2022PSYC’s Bonfire Platform Development Progresses; Will Host Free Virtual Community Event on August 29th

Can CBD Oil Help Fix Healthcare?

Jul 8, 2017 • 1:05 PM EDT
5 MIN READ  •  By Michael Berger
Share Share - Facebook Share - Twitter

Political Analyst – Derek Thomas

No matter your political affiliation, most people can agree that health care in the United States is in desperate need of repair. Both sides of the aisle have their issues with America’s health care system, and both sides are right AND wrong. Meanwhile, patients suffer with both ongoing illness and unaffordable costs. A combined approach tackling political, insurance, regulatory, cultural, and lifestyle issues would put us on a path towards real positive change – but we’re not going to accomplish all of that anytime soon.

We can have a pretty realistic conversation about one solution and how many issues that one solution could solve – and it’s been sitting right in front of our faces for thousands of years. We’re talking about CBD Oil (and for simplicities sake were talking about all the varieties of CBD compounds found in cannabis).

In fact, cannabis was known for thousands of years as a medicine and not a narcotic. It was only within the last 100 years that propaganda changed the cultural sentiments about cannabis. Now that technology has allowed us to study and isolate CBD’s we have an even stronger understanding of their specific benefits. A recent article by Forbes.com listed the top 5 problems with healthcare. Let’s look at how CBD Oil could help solve some of these issues.

Too much unnecessary health care was listed as the first issue. Between over-prescribing medication to redundant testing and procedures that aren’t needed, our health care system is bogged down by unnecessary health care. Prescription medications are a big part of that. Consider the resources that one prescription drug ties up in the health care system. Further that thought with the fact that the vast majority of prescriptions treat one specific ailment. CBD oil, on the other hand, is a fairly cost-effective compound to extract and is easy to adjust both in concentration and delivery method. The slam-dunk is CBD’s ability to treat so many illnesses in this cost-effective way.

For example, patient number one is diagnosed with social-anxiety disorder and suffers from chronic back pain. They would more than likely be taking a daily pill regiment of Prozac, Xanax, and Celebrex. Patient two has the same diagnosis but only takes CBD oil, probably as an ingestible for the anxiety and a topical for the back pain. How much simpler of a solution is that? We’ve just cut down drastically on resources needed to treat one patient’s ailments. We’ve avoided all the red tape of complicated lab procedures for three medications by manufacturing one simple solution from the earth.

Problem number two, according to Forbes, is avoidable harm to patients. This one almost goes without saying, but let’s say it anyways. We’re going back to patient one and two. Patient one’s side effects from his medications could include: dizziness, nausea, constipation, insomnia, decreased sex drive, impotence, difficulty reaching orgasm, rapid weight gain, thoughts of suicide, atrial fibrillation, liver failure, kidney failure, mania, seizures, stroke, hives, and loss of memory – to name a few! Patient number two has a very small chance of noticing dry mouth and slowed motor skills. And usually those side effects are found in lower quality CBD oil. There may not be a stronger case in all of healthcare for avoidable harm done to patients than the overprescribing of prescription drugs where CBD oil could be used instead.

We couldn’t agree more with Forbes number three point, that billions of dollars – possibly as much as 1/3 – of health care costs are wasted. Those same labs that manufacture over-prescribed drugs are bogged down with costs from regulation insurance which in turn raise overhead to incredible highs. These costs are transferred right onto patients which in turn not only raise the cost of drugs but also of healthcare premiums. It’s really a vicious cycle! As more drugs are prescribed, more drugs are needed to alleviate the side effects of the first drugs, which in turn all raises the price of the drugs which creates more stress, uncertainty, and unhealthy action in patients which leads to more drugs!

CBD Oil could easily save consumers billions of dollars as it is relatively easy and cost effective to produce. Once the industry is federally legal and regulated, there will be some regulation – which is needed – costs may rise, but will still be incredibly lower than current prescription costs.

Finally, the last two problems in the article can be mitigated in one point by CBD Oil. Both the perverse incentives for payment in health care and a lack of transparency are the symptoms of an industry consumed with the motivation for profit. I’m a capitalist through and through, but capitalism implies fair competition – and there is clearly a lack of that in health care. Often times, a product wins the hearts and minds of consumers because of the values that the company manufacturing it upholds. I cannot think of one single drug manufacturer or insurance provider that is regarded as ethical or moral, resulting in a perverse payment system and a lack of transparency.

But I have traveled this country and met many CBD Oil manufacturers. The majority are forward thinking kind-hearted individuals that want the best for their patients. Their risking legal trouble bankruptcy to help people and despite the hurdles facing them often still strive for the triple bottom line of profits, people, and the planet for their businesses. It is not CBD Oil itself that can fix perverse incentives or a lack of transparency, it is the entrepreneurs behind the brands that can.

Share Share - Facebook Share - Twitter


Authored By

Michael Berger

Michael Berger is Managing Partner of StoneBridge Partners, LLC and Founder of Mushroomstocks.com. Prior to entering the cannabis industry, Michael was an Equity Research Analyst at Raymond James Financial covering the Energy Sector. Michael has been featured in publications such as The Street, Bloomberg, US Money News, and hosts various cannabis events across North America.


Top Stories

Get the Latest Cannabis News & Stock Picks.

Enter your email below to join the official Mushroomstocks newsletter.

 All good -- no spamming here.

The psychedelics sector is starting to take off as smart money begins to position itself across the industry.

Stay updated with all latest updates,upcoming events & much more.

Fatal error: Uncaught ErrorException: md5_file(/home/useaicwl/public_html/wp-content/litespeed/css/d48b180c23ceca0142ec5082160b970c.css.tmp): failed to open stream: No such file or directory in /home/useaicwl/public_html/wp-content/plugins/litespeed-cache/src/optimizer.cls.php:126 Stack trace: #0 [internal function]: litespeed_exception_handler(2, 'md5_file(/home/...', '/home/useaicwl/...', 126, Array) #1 /home/useaicwl/public_html/wp-content/plugins/litespeed-cache/src/optimizer.cls.php(126): md5_file('/home/useaicwl/...') #2 /home/useaicwl/public_html/wp-content/plugins/litespeed-cache/src/optimize.cls.php(797): LiteSpeed\Optimizer->serve('https://mushroo...', 'css', true, Array) #3 /home/useaicwl/public_html/wp-content/plugins/litespeed-cache/src/optimize.cls.php(319): LiteSpeed\Optimize->_build_hash_url(Array) #4 /home/useaicwl/public_html/wp-content/plugins/litespeed-cache/src/optimize.cls.php(252): LiteSpeed\Optimize->_optimize() #5 /home/useaicwl/public_html/wp-includes/class-wp-hook.php(310): LiteSpeed\Optimize->f in /home/useaicwl/public_html/wp-content/plugins/litespeed-cache/src/optimizer.cls.php on line 126